The popularity of Sildenafil initially drove a period of growth for the drug industry, nevertheless recent shifts present a murky scenario for investors. Generic competitors are eroding profits, and continued https://graysonptcn449292.aboutyoublog.com/52663414/the-blue-pill-and-big-pharma-a-volatile-investment